Bioactivity | MPH-220 is a selective and orally active inhibitor of skeletal muscle myosin-2. MPH-220 enables muscle relaxation. MPH-220 is anti-spastic agent that can be used in the research of spasticity and muscle stiffness[1]. |
Invitro | MPH-220 (0-50 µM) 抑制人肌肉肌球蛋白样品中肌动蛋白激活的 ATP 酶活性[1]。 |
In Vivo | MPH-220 (25-30 mg/kg,腹腔注射或口服灌胃) 可降低麻醉大鼠的骨骼肌力量,而不会影响心血管[1]。MPH-220 (15 mg/kg,口服) 改善脑损伤大鼠的步态功能[1]。 Animal Model: |
Name | MPH-220 |
CAS | 2649776-79-2 |
Formula | C20H21N3O3S |
Molar Mass | 383.46 |
Transport | Room temperature in continental US; may vary elsewhere. |
Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Reference | [1]. Gyimesi M, et al. Single Residue Variation in Skeletal Muscle Myosin Enables Direct and Selective Drug Targeting for Spasticity and Muscle Stiffness. Cell. 2020 Oct 15;183(2):335-346.e13. |